BMS-911543

DB12591InvestigationalSmall molecule

BMS-911543 has been used in trials studying the treatment of Cancer.

Mechanism: Pharmacologically active on Tyrosine-protein kinase JAK2
Curator reviewed
Formula / weight: C₂₃H₂₈N₈O · 432.532 g/mol (avg)
Code names: BMS-911543

Resolves to

Compound

Structure

InChIKeyJCINBYQJBYJGDM-UHFFFAOYSA-NSMILESCCN1C(=CC2=C3N(C)C=NC3=C(NC3=NN(C)C(C)=C3)N=C12)C(=O)N(C1CC1)C1CC1

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with BMS-911543, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.